Description
Product Description :
GHRPs are a small family of peptides acting at the pituitary and the hypothalamus to release Growth hormone (GH) through the activation of a specific, G protein-coupled receptor.
Growth Hormone Releasing Peptide 2(GHRP2) substantially stimulates the pituitary gland’s increased natural production of the body’s own endogenous human growth hormone (HGH). This therapy consists of daily periodic sub-lingual dosing. Growth Hormone releasing peptide 2, GHRP2 has shown on it’s own to robustly increase IGF-1 levels, and even greater results occurred when used with Growth Hormone Releasing Hormone (GHRH) to which also stimulates the pituitary gland to produce increased natural secretion of human growth hormone. This also boosts the hypothalamus function as well.
The results of the clinical studies published in the Journal of Endocrinology and Metabolism in 1997 for GHRP2 – showed that a medically supervised, prescribed and administered therapy increased growth hormone levels in adults and children, who have growth hormone deficiency.
The increase in the body’s growth hormone via elevated IGF-1 levels produced by the pituitary gland in response to GHRP2 therapy — has an anabolic effect on the tissues of the body and other benefits identified below.
